MAKERSLPharmaceuticals
Makers Laboratories Ltd — Profit & Loss Statement
₹135.20
-4.21%
Makers Laboratories Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | -0.15 Cr | 0.00 | -0.05 Cr | -0.05 Cr | — |
| Tax Rate For Calcs | 0.19 | 0.30 | 0.30 | 0.25 | — |
| Normalized EBITDA | 20.27 Cr | 2.58 Cr | 5.69 Cr | 21.58 Cr | — |
| Total Unusual Items | -0.79 Cr | 0.00 | -0.17 Cr | -0.19 Cr | — |
| Total Unusual Items Excluding Goodwill | -0.79 Cr | 0.00 | -0.17 Cr | -0.19 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 7.49 Cr | -6.26 Cr | -4.75 Cr | 4.98 Cr | — |
| Reconciled Depreciation | 4.79 Cr | 4.54 Cr | 4.24 Cr | 4.02 Cr | — |
| Reconciled Cost Of Revenue | 54.07 Cr | 54.43 Cr | 61.86 Cr | 74.12 Cr | — |
| EBITDA | 19.48 Cr | 2.58 Cr | 5.52 Cr | 21.39 Cr | — |
| EBIT | 14.70 Cr | -1.96 Cr | 1.28 Cr | 17.37 Cr | — |
| Net Interest Income | -1.28 Cr | -1.95 Cr | -1.32 Cr | -0.99 Cr | — |
| Interest Expense | 1.28 Cr | 1.95 Cr | 2.12 Cr | 1.68 Cr | — |
| Normalized Income | 8.13 Cr | -6.26 Cr | -4.63 Cr | 5.12 Cr | — |
| Net Income From Continuing And Discontinued Operation | 7.49 Cr | -6.26 Cr | -4.75 Cr | 4.98 Cr | — |
| Total Expenses | 117.15 Cr | 107.88 Cr | 101.57 Cr | 111.47 Cr | — |
| Diluted NI Availto Com Stockholders | 7.49 Cr | -6.26 Cr | -4.75 Cr | 4.98 Cr | — |
| Net Income Common Stockholders | 7.49 Cr | -6.26 Cr | -4.75 Cr | 4.98 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 7.49 Cr | -6.26 Cr | -4.75 Cr | 4.98 Cr | — |
| Minority Interests | -3.42 Cr | -1.45 Cr | -2.56 Cr | -6.74 Cr | — |
| Net Income Including Noncontrolling Interests | 10.91 Cr | -4.81 Cr | -2.19 Cr | 11.72 Cr | — |
| Net Income Continuous Operations | 10.91 Cr | -4.81 Cr | -2.19 Cr | 11.72 Cr | — |
| Tax Provision | 2.50 Cr | 0.89 Cr | 1.35 Cr | 3.97 Cr | — |
| Pretax Income | 13.41 Cr | -3.92 Cr | -0.84 Cr | 15.69 Cr | — |
| Other Non Operating Income Expenses | 11.89 Cr | 1.53 Cr | 0.67 Cr | 1.35 Cr | — |
| Special Income Charges | -0.79 Cr | 0.00 | -0.17 Cr | -0.27 Cr | — |
| Other Special Charges | 0.79 Cr | -41000.00 | -41000.00 | 0.21 Cr | — |
| Net Non Operating Interest Income Expense | -1.28 Cr | -1.95 Cr | -1.32 Cr | -0.99 Cr | — |
| Interest Expense Non Operating | 1.28 Cr | 1.95 Cr | 2.12 Cr | 1.68 Cr | — |
| Operating Income | 3.60 Cr | -3.49 Cr | -0.73 Cr | 15.09 Cr | — |
| Operating Expense | 63.08 Cr | 53.45 Cr | 39.71 Cr | 37.35 Cr | — |
| Other Operating Expenses | 44.25 Cr | 34.97 Cr | 17.08 Cr | 12.63 Cr | — |
| Depreciation And Amortization In Income Statement | 4.79 Cr | 4.54 Cr | 4.24 Cr | 4.02 Cr | — |
| Depreciation Income Statement | 4.79 Cr | 4.54 Cr | 4.16 Cr | 3.91 Cr | — |
| Gross Profit | 66.68 Cr | 49.96 Cr | 38.98 Cr | 52.44 Cr | — |
| Cost Of Revenue | 54.07 Cr | 54.43 Cr | 61.86 Cr | 74.12 Cr | — |
| Total Revenue | 120.75 Cr | 104.39 Cr | 100.84 Cr | 126.56 Cr | — |
| Operating Revenue | 120.75 Cr | 104.39 Cr | 100.84 Cr | 126.56 Cr | — |
| Interest Income | — | 0.59 Cr | 0.88 Cr | 0.75 Cr | 0.11 Cr |
| Rent Expense Supplemental | — | 0.47 Cr | 0.35 Cr | 0.27 Cr | 0.31 Cr |
| Diluted Average Shares | — | 0.59 Cr | 0.60 Cr | 0.51 Cr | 0.49 Cr |
| Basic Average Shares | — | 0.59 Cr | 0.60 Cr | 0.51 Cr | 0.49 Cr |
| Diluted EPS | — | -10.62 | -7.90 | 9.71 | -0.67 |
| Basic EPS | — | -10.62 | -7.90 | 9.71 | -0.67 |
| Write Off | — | 0.15 Cr | 0.18 Cr | 0.06 Cr | 0.98 Cr |
| Total Other Finance Cost | — | 0.06 Cr | 0.07 Cr | 0.06 Cr | 0.05 Cr |
| Interest Income Non Operating | — | 0.59 Cr | 0.88 Cr | 0.75 Cr | 0.11 Cr |
| Amortization | — | 0.10 Cr | 0.08 Cr | 0.11 Cr | 0.03 Cr |
| Research And Development | — | 0.13 Cr | 0.26 Cr | 0.53 Cr | 0.24 Cr |
| Selling General And Administration | — | 5.77 Cr | 5.71 Cr | 7.23 Cr | 4.55 Cr |
| Selling And Marketing Expense | — | 4.26 Cr | 4.40 Cr | 5.91 Cr | 3.57 Cr |
| General And Administrative Expense | — | 1.51 Cr | 1.30 Cr | 1.32 Cr | 0.97 Cr |
| Rent And Landing Fees | — | 0.47 Cr | 0.35 Cr | 0.27 Cr | 0.31 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Makers Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.